Oncology News | pharmaphorum

News

'Inadvertent' leak teases survival benefit for Roche's TIGIT

In an unusual development, Roche has put out a statement this morning acknowledging an "inadvertent disclosure" of data from its SKYSCRAPER-01 study of anti-TIGIT drug tir

News

FDA places Gilead's CD47 drug on another clinical hold

Gilead is dealing with more turbulence in its development of CD47-targeting antibody magrolimab, with a partial clinical hold placed on the drug by the FDA in acute myeloi

News

UK study prompts call for MRI screening for prostate cancer

A UK study has suggested that a 10-minute MRI scan is more effective at detecting prostate cancer than testing for blood levels of the biomarker PSA, picking up serious ca

News

Trial backs use of Cabometyx, Tecentriq in prostate cancer

Ipsen and Exelixis could expand the use of blockbuster oncology drug Cabometyx into prostate cancer, based on data from a phase 3 study – and help bring a cancer immunothe

News

OneOncology taps Verily for clinical trials platform

OneOncology has joined forces with Verily to speed up and improve the efficiency of clinical trials run through its network of independent cancer treatment centres in the

News

One in five men carries HPV linked to cancer

Researchers have estimated that almost one in three men worldwide is infected with at least one genital human papillomavirus (HPV) strain, and one in five is harbouring st

'Inadvertent' leak teases survival benefit for Roche's TIGIT

FDA places Gilead's CD47 drug on another clinical hold

UK study prompts call for MRI screening for prostate cancer

Trial backs use of Cabometyx, Tecentriq in prostate cancer

OneOncology taps Verily for clinical trials platform

One in five men carries HPV linked to cancer

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks